Wang · Drug design, development and therapy 2017 · narrative review · n=?

Regulation profile of the intestinal peptide transporter 1 (PepT1).

Cited 106 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of biological mechanisms and drug transport without systematic review methodology.

PubMed 29263649 · doi:10.2147/DDDT.S151725 · record verified 2026-08-29

What was done

This paper provides a narrative review summarizing literature and research progress on the intestinal peptide transporter 1 (PepT1), focusing on its transcriptional and post-transcriptional regulation and its role in dietary peptide absorption and prodrug design.

What was found

The abstract reports no quantitative experimental data or numerical outcomes. It notes that PepT1 facilitates the absorption of over 400 dipeptides and 8,000 tripeptides from dietary proteins as well as structurally related peptidomimetic drugs (such as anticancer and antiviral agents), and that its expression and activity are regulated by multiple factors at the transcriptional and post-transcriptional levels.

Why it matters

Understanding PepT1 regulation aids in optimizing dietary peptide absorption and informs rational prodrug design to enhance oral bioavailability for peptide-like therapeutics.

Limits

As a narrative review, the paper lacks systematic search criteria, quality appraisal of included studies, and primary quantitative experimental or clinical data in the abstract.

Cited by